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Background: We assessed the trend, predictors and operator volume inﬂuence of
complication related to Percutaneous closure of atrial septal defect (ASD) and patent
foramen ovale (PFO).
Methods: We examined the Healthcare Cost and Utilization Project's Nationwide
Inpatient Sample (NIS) database from 2001 to 2010 using ICD 9-CM code for
percutaneous ASD/PFO closure (35.52). Only adult (age > 18 year) patients with
ASD/PFO (ICD 9-CM – 745.5) Procedural were included in study. NIS is represents
20% of all US hospitals. Complications were identiﬁed using Patient Safety Indicators
(PSIs) and ICD-9-CM codes. Comorbid conditions were deﬁned by Charlson's
Comorbidity Index (CCI). Annual operator and hospital volume was calculated using
unique identiﬁcation numbers and then divided in tertiles for analysis. Hierarchical
multilevel regression models were generated to determine independent predictors of
peri-procedural complication.
Results: Total of 7,107 (weighted n ¼ 34,990) percutaneous ASD/PFO closure
procedures were analyzed. Cardiac complications (3.4%) were most common
complication. Signiﬁcant predictors (OR, 95% CI, P-value) of increased complications
were presence of increasing comorbidities (CCI > 2) (2.89, 2.11-3.96, p<0.001),
emergent/urgent admission (1.60, 1.23-2.09, p<0.001). Highest tertile of annual
operator volume (0.35, 0.25- 0.51, p< 0.001) was associated with lower complication
rate.Conclusions: Vascular and cardiac complications are commonest complication
related to ASD/PFO closure. Increasing annual operator volume is signiﬁcant
predictor of lower complication rates.B208 JACC Vol 62/18/Suppl B j October 27–November 1,TCT-680
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Background: Ruptured sinus of Valsalva (RSOV) has traditionally been managed by
surgery. There are a few case series which do highlight the signiﬁcant role of
Percutaneous intervention for RSOV . The relative concern about the interventional
procedure has been persistent unsupported aneurysm that persist even after closure of
the defect which would only reﬂect in follow up studies.
Methods: Patients with isolated rupture of the sinus of Valsalva (RSOV),
n¼13 who underwent transcatheter device closure were reviewed with their
follow up.
Results: There were a total of 13 patients. The mean age was 39  10.0 years. New
York Heart Association (NYHA) class at the time of presentation was II (six
patients) and III (six patients), class iv (one patient). The RSOVs were all closed
using a patent ductus arteriosus device. The mean procedural time was 30  5.4
minutes, while the ﬂuoroscopic time was 20  7 minutes. The average hospital stay
was 2  1.1 days. There was one on table mortality. The patients were followed up
for a mean of 3 years (ranging from 1 month to 5 years). All had complete closure of
the shunt in follow up . During the learning curve we modiﬁed the technique making
subtle changes such as use of buddy wire, kissing technique for right ventricular
outﬂow tract opening and use of braided sheaths for the same. At the time of the last
follow up all the patients were in NYHA class I and there was one hospital mortality,
latter highlighting the importance of case selection for the procedure. No increase in
distortion indices viz aortic annulus, aortic root, St junction and ascending aortic
dimensions were observed.
Conclusions: We conclude transcatheter closure of isolated RSOV is a viable alter-
native to surgical repair with good outcome on echocardiographic follow up .Though
a long term data is required particularly with respect to aortic root distortion evaluated
by other imaging modality like CT scan or MRI.TCT-681
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Background: We assessed the trends and predictors of complication related to Left
Atrial Appendage (LAA) closure.
Methods: We included cases from Healthcare Cost and Utilization Project's Nation-
wide Inpatient Sample (NIS) database from year 2006 to 2010 using ICD9 procedure
code 37.90 for percutaneous LAA Closure. NIS is the largest all-payer database which
represents 20% of all US hospitals. We used Deyo modiﬁcation of Charlson's
Comorbidity Index (CCI) to deﬁne comorbidities. Procedural complications were
identiﬁed using Patient Safety Indicators (PSIs) and ICD-9-CM codes. Annual
hospital volume was calculated using unique hospital identiﬁer. Hierarchical multi-
level regression models were generated to determine independent predictors of peri-
procedural complication.
Results: We identiﬁed total of 1288 procedures,majority were performed in
large teaching hospitals. Overall periprocedural complication rate was 24.6%.
Notable complications were cardiac (12.4%), Vascular (4.5%), respiratory
(5.7%) and neurological (3.3%). CCI > 2 (OR¼3.85, 1.39-10.72, P¼0.01) was
associated with increased complication whereas higher annual hospital volume
(OR¼0.002, 0.0 -0.027, P<0.001) was associated with lower complication rate.
Procedures performed with the use of intra-cardiac echocardiography (ICE) had
lower rate of cardiac complication (5.4% with ICE vs. 12.4% with no
ICE, P<0.001) and overall mortality (0% with ICE vs. 2.4% with no ICE,
P<0.001).2013 j TCT Abstracts/POSTER/Non-valvular Structural Heart Disease
